Prot# D0620C00004: A Placebo-Controlled, Double-Blind, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of Single and Multiple Intravenous Infusions of CytoFab (AZD9773) in Patients with Severe Sepsis

Project: Research project

Project Details

StatusFinished
Effective start/end date12/5/07 → 12/5/10

Funding

  • Parexel (D0620C00004 // D0620C00004)
  • AstraZeneca Pharmaceuticals LP (D0620C00004 // D0620C00004)